• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:最小化治疗后结核自回归及文献综述

Case Report: Tuberculosis Autoregression after Minimal Treatment and Review of the Literature.

作者信息

Walter Chelsea, Acuña-Villaorduna Carlos, Hochberg Natasha S, Sinha Pranay

机构信息

Section of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts.

Lemuel Shattuck Hospital, Department of Public Health, Boston, Massachusetts.

出版信息

Am J Trop Med Hyg. 2022 Aug 15;107(3):595-9. doi: 10.4269/ajtmh.21-0839.

DOI:10.4269/ajtmh.21-0839
PMID:35970288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9490661/
Abstract

Mycobacterium tuberculosis (Mtb) is a complex pathogen causing multiple possible disease states in its host including latency, active disease, and elimination. While there is reasonable indirect evidence of elimination of tuberculosis (TB) in the absence of treatment, direct reports of autoregression are rare. We report a case of smear-negative, polymerase chain reaction (PCR)-positive TB disease regression in the absence of therapy due to severe adverse effects from antimycobacterial drugs. Indirect reports of TB autoregression, or self-cure, in the literature are reviewed, and an updated framework for conceptualizing Mtb infection is discussed.

摘要

结核分枝杆菌(Mtb)是一种复杂的病原体,可在其宿主中引发多种可能的疾病状态,包括潜伏、活动性疾病和清除。虽然有合理的间接证据表明在未经治疗的情况下结核病(TB)可被清除,但关于自愈的直接报道却很少。我们报告了一例因抗分枝杆菌药物严重不良反应而未经治疗的涂片阴性、聚合酶链反应(PCR)阳性的结核病病情消退病例。本文回顾了文献中关于结核病自愈的间接报道,并讨论了一个更新的结核分枝杆菌感染概念框架。

相似文献

1
Case Report: Tuberculosis Autoregression after Minimal Treatment and Review of the Literature.病例报告:最小化治疗后结核自回归及文献综述
Am J Trop Med Hyg. 2022 Aug 15;107(3):595-9. doi: 10.4269/ajtmh.21-0839.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
Tuberculosis结核病
4
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核及利福平耐药性的Xpert® MTB/RIF检测法
Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3.
5
[Prospects for development of new antituberculous drugs].[新型抗结核药物的发展前景]
Kekkaku. 2002 Aug;77(8):573-84.
6
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
7
Clinical utility of an amplification test based on ligase chain reaction in pulmonary tuberculosis.基于连接酶链反应的扩增试验在肺结核中的临床应用
Am J Respir Crit Care Med. 1998 Oct;158(4):1096-101. doi: 10.1164/ajrccm.158.4.9801112.
8
COMPARISON OF GeneXpert MTB/RIF ASSAY WITH CONVENTIONAL AFB SMEAR FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN NORTHEASTERN THAILAND.泰国东北部地区采用GeneXpert MTB/RIF检测法与传统抗酸杆菌涂片法诊断肺结核的比较
Southeast Asian J Trop Med Public Health. 2017 Mar;48(2):313-21.
9
Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.德国医院结核疑似患者中 Xpert MTB/RIF 的成本效益分析。
Eur Respir J. 2016 Feb;47(2):575-87. doi: 10.1183/13993003.01333-2015. Epub 2015 Dec 2.
10
Infectiousness of patients with smear-negative pulmonary tuberculosis, assessed by Real-time Polymerase Chain Reaction, XpertMTB/RIF.实时聚合酶链反应、XpertMTB/RIF 评估菌阴肺结核患者的传染性。
J Infect. 2020 Mar;80(3):298-300. doi: 10.1016/j.jinf.2019.12.023. Epub 2020 Jan 16.

引用本文的文献

1
Delayed diagnosis of pulmonary tuberculosis with pleuritis due to ampicillin/sulbactam: A case report.氨苄西林/舒巴坦导致胸膜炎型肺结核的延迟诊断:一例报告
World J Clin Cases. 2025 Jul 6;13(19):104083. doi: 10.12998/wjcc.v13.i19.104083.
2
Tuberculosis "Autoregression": A Historical Context.结核病“自回归”:历史背景
Am J Trop Med Hyg. 2022 Dec 12;108(1):235-236. doi: 10.4269/ajtmh.22-0590.

本文引用的文献

1
Diabetes Status and Association With Risk of Tuberculosis Among Korean Adults.韩国成年人的糖尿病状况与结核病风险的关联。
JAMA Netw Open. 2021 Sep 1;4(9):e2126099. doi: 10.1001/jamanetworkopen.2021.26099.
2
Tuberculosis sanatorium treatment at the advent of the chemotherapy era.抗结核化学药物治疗时代以前的疗养院治疗。
BMC Infect Dis. 2020 Nov 11;20(1):831. doi: 10.1186/s12879-020-05539-w.
3
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.潜伏结核感染治疗指南:美国国家结核病控制协会和美国疾病预防控制中心 2020 年推荐意见。
MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. doi: 10.15585/mmwr.rr6901a1.
4
Estimating Long-term Tuberculosis Reactivation Rates in Australian Migrants.估算澳大利亚移民中的潜伏性结核再激活率。
Clin Infect Dis. 2020 May 6;70(10):2111-2118. doi: 10.1093/cid/ciz569.
5
Revisiting the timetable of tuberculosis.重新审视结核病的时间表。
BMJ. 2018 Aug 23;362:k2738. doi: 10.1136/bmj.k2738.
6
Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.潜伏性和亚临床性结核病:感染早期阶段和进展的临床评估。
Clin Microbiol Rev. 2018 Jul 18;31(4). doi: 10.1128/CMR.00021-18. Print 2018 Oct.
7
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection.人体抵抗持续结核分枝杆菌感染的免疫机制。
Nat Rev Immunol. 2018 Sep;18(9):575-589. doi: 10.1038/s41577-018-0025-3.
8
Heterogeneity in tuberculosis.结核病的异质性。
Nat Rev Immunol. 2017 Nov;17(11):691-702. doi: 10.1038/nri.2017.69. Epub 2017 Jul 24.
9
Chemotherapy of Tuberculosis.结核病化疗。
Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0040-2017.
10
Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa.南非接受门诊治疗的晚期艾滋病毒感染成人中结核病及其他潜在可治疗感染的尸检患病率
PLoS One. 2016 Nov 9;11(11):e0166158. doi: 10.1371/journal.pone.0166158. eCollection 2016.